NBRC Pharmacology Practice Exam 2026 - Free NBRC Pharmacology Practice Questions and Review Guide

Flolan, the brand name for epoprostenol, is primarily indicated for the treatment of pulmonary hypertension, a condition characterized by elevated blood pressure in the pulmonary arteries. This medication is a potent vasodilator that works by relaxing and dilating blood vessels in the lungs, which leads to a decrease in pulmonary artery pressure. By improving blood flow and reducing the workload on the heart, Flolan helps alleviate symptoms associated with pulmonary hypertension, such as shortness of breath and fatigue.

This targeted action is particularly vital for patients suffering from primary pulmonary hypertension or pulmonary hypertension associated with conditions like scleroderma or congenital heart disease. The effectiveness of Flolan in managing this specific condition underscores its importance in the therapeutic landscape of pulmonary vascular diseases, making it the correct answer to this question.